Literature DB >> 3426895

Impaired vagal heart rate control in coronary artery disease.

K E Airaksinen1, M J Ikäheimo, M K Linnaluoto, M Niemelä, J T Takkunen.   

Abstract

Heart rate variation in deep breathing, a sensitive non-invasive measure of cardiac parasympathetic activity, was measured in 63 patients with coronary artery disease, in 22 patients with atypical chest pain, and in 20 healthy symptom free volunteers. There was significantly less heart rate variation in deep breathing in the patients with coronary artery disease than in the healthy subjects. Twenty patients (32%) with coronary artery disease had lower than normal variation in heart rate. The patients with chest pain showed an intermediate heart rate response to deep breathing. Sinus arrhythmia in the patients with coronary artery disease was not related to the functional class, medication, number or location of narrowed vessels, or to the left ventricular ejection fraction, and end diastolic pressure. These results suggest that impairment of the parasympathetic nervous function is common in coronary artery disease.

Entities:  

Mesh:

Year:  1987        PMID: 3426895      PMCID: PMC1277310          DOI: 10.1136/hrt.58.6.592

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  29 in total

1.  Peripheral muscarinic control of norepinephrine release in the cardiovascular system.

Authors:  E Muscholl
Journal:  Am J Physiol       Date:  1980-12

Review 2.  Diagnosis and management of diabetic autonomic neuropathy.

Authors:  D J Ewing; B F Clarke
Journal:  Br Med J (Clin Res Ed)       Date:  1982-10-02

3.  Baroreceptor reflex control of heart rate: a predictor of sudden cardiac death.

Authors:  G E Billman; P J Schwartz; H L Stone
Journal:  Circulation       Date:  1982-10       Impact factor: 29.690

4.  Cardiac autonomic neuropathy in diabetes: comparison of measures of R-R interval variation.

Authors:  D J Ewing; D Q Borsey; F Bellavere; B F Clarke
Journal:  Diabetologia       Date:  1981-07       Impact factor: 10.122

5.  The effects of daily exercise on susceptibility to sudden cardiac death.

Authors:  G E Billman; P J Schwartz; H L Stone
Journal:  Circulation       Date:  1984-06       Impact factor: 29.690

6.  Quantitative evaluation of cardiac parasympathetic activity in normal and diabetic man.

Authors:  M A Pfeifer; D Cook; J Brodsky; D Tice; A Reenan; S Swedine; J B Halter; D Porte
Journal:  Diabetes       Date:  1982-04       Impact factor: 9.461

7.  Autonomic mechanisms in ventricular fibrillation induced by myocardial ischemia during exercise in dogs with healed myocardial infarction. An experimental preparation for sudden cardiac death.

Authors:  P J Schwartz; G E Billman; H L Stone
Journal:  Circulation       Date:  1984-04       Impact factor: 29.690

8.  Differential changes of autonomic nervous system function with age in man.

Authors:  M A Pfeifer; C R Weinberg; D Cook; J D Best; A Reenan; J B Halter
Journal:  Am J Med       Date:  1983-08       Impact factor: 4.965

9.  Impaired baroreflex control of vascular resistance and heart rate in acute myocardial infarction.

Authors:  T Imaizumi; A Takeshita; N Makino; T Ashihara; K Yamamoto; M Nakamura
Journal:  Br Heart J       Date:  1984-10

10.  Cardiovascular reflexes in patients after myocardial infarction. Effect of long-term treatment with beta-adrenoceptor antagonists.

Authors:  T Bennett; R G Wilcox; J R Hampton
Journal:  Br Heart J       Date:  1980-09
View more
  21 in total

1.  The relationship between heart rate recovery and heart rate variability in coronary artery disease.

Authors:  Harun Evrengul; Halil Tanriverdi; Sedat Kose; Basri Amasyali; Ayhan Kilic; Turgay Celik; Hasan Turhan
Journal:  Ann Noninvasive Electrocardiol       Date:  2006-04       Impact factor: 1.468

2.  Asymptomatic coronary artery disease in diabetes: associated with autonomic neuropathy?

Authors:  M J Koistinen; K E Airaksinen; H V Huikuri; H Pirttiaho; M K Linnaluoto; M J Ikäheimo; J T Takkunen
Journal:  Acta Diabetol       Date:  1992       Impact factor: 4.280

3.  The prevalence and diagnostic/prognostic utility of sinus arrhythmia in the evaluation of congenital long QT syndrome.

Authors:  Jonathan N Johnson; Michael J Ackerman
Journal:  Heart Rhythm       Date:  2010-07-29       Impact factor: 6.343

4.  The additional impact of type 2 diabetes on baroreflex sensitivity of coronary artery disease patients might be undetectable in presence of deterioration of mechanical vascular properties.

Authors:  Mariana de Oliveira Gois; Alberto Porta; Rodrigo Polaquini Simões; Vandeni Clarice Kunz; Patricia Driusso; Humberto Sadanobu Hirakawa; Beatrice De Maria; Aparecida Maria Catai
Journal:  Med Biol Eng Comput       Date:  2019-03-07       Impact factor: 2.602

5.  Patients with uncomplicated coronary artery disease have reduced heart rate variability mainly affecting vagal tone.

Authors:  B Wennerblom; L Lurje; H Tygesen; R Vahisalo; A Hjalmarson
Journal:  Heart       Date:  2000-03       Impact factor: 5.994

6.  Decreased heart rate variability in survivors of sudden cardiac death not associated with coronary artery disease.

Authors:  L Fei; M H Anderson; D Katritsis; J Sneddon; D J Statters; M Malik; A J Camm
Journal:  Br Heart J       Date:  1994-01

7.  Differences in autonomic nerve function in patients with silent and symptomatic myocardial ischaemia.

Authors:  C F Shakespeare; D Katritsis; A Crowther; I C Cooper; J D Coltart; M W Webb-Peploe
Journal:  Br Heart J       Date:  1994-01

8.  Cardiac dysrhythmias during cardiovascular autonomic reflex tests.

Authors:  S J Piha; L M Voipio-Pulkki
Journal:  Clin Auton Res       Date:  1993-06       Impact factor: 4.435

9.  Autonomic function in hypertrophic cardiomyopathy.

Authors:  D M Gilligan; W L Chan; E Sbarouni; P Nihoyannopoulos; C M Oakley
Journal:  Br Heart J       Date:  1993-06

10.  Intravenous nifedipine for prevention of myocardial ischaemia after coronary revascularization.

Authors:  J Y Dupuis; H J Nathan; S Laganière
Journal:  Can J Anaesth       Date:  1992-12       Impact factor: 5.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.